Meeting Banner
Abstract #1470

Pharmacokinetic Parameter of DCE-MRI and US-Localized Optical Imaging in Breast Cancer: According to Pathologic Biomarker

Min Jung Kim1, 2, Ji Soo Choi1, Hon J Yu, Jeon-Hor Chen, Min-Ying Su, Eun-Kyung Kim1, Hee Jung Moon1

1Radiology, Yonsei University College of Medicine, Seoul, Korea, Republic of; 2John Tu and Thomas Yuen Center for Functional Oncoimaging, UC Irvine, Irvine, CA, United States

 

Keywords

absorption aggressive aggressiveness almost among analyzed annals applied association august autonomous axillary body breast brown cancer carcinoma cell chance chemotherapy clinical coded color coming complementary concentration consistent contrast coronal correlation critical depth determined diagnostic diameter diffuse distinct dynamic employed encompassing enhanced enhancement entire estrogen features fern functional grade growth guinea helpful hemoglobin heterogeneous important included indicates infrared interpretation invasive john journal kinetic kinetics lack larger lesions limitation localized lymph margins marker mass materials maximal measure measured measuring metastasis mets modality molecular nature near negative nuclear oncology optical oxygen pathologic pathology patients percentage permeability placed poor poorer positive prediction presence previous progesterone prognosis prognostic proliferation propagation properties providing quality radiology receptor reconstructed reflected related republic respectively response saturation scale section separated seven sign significantly skin slice slices smaller spacing spatial spread statistical student studies surface surgical table technology therapy thin thirty tomography tumor tumors underwent useful utilizes variation vascular whether wide year